Literature DB >> 105012

A study of human leukocyte D locus related antigens in Graves' disease.

N R Farid, L Sampson, E P Noel, J M Barnard, R Mandeville, B Larsen, W H Marshall, N D Carter.   

Abstract

An association between Graves' disease and the human leukocyte antigen (HLA) system has previously been reported. The disease was more strongly associated with the HLA D locus antigen Dw3 than with HLA B8. Products of the HLA D locus are determined by the interaction of test cells with standard typing lymphocytes, a technically difficult procedure. Recently, it has been possible to type serologically for D locus related (DRw) specificities on peripheral bone marrow-derived (B) lymphocytes. Blood B lymphocytes from 50 unrelated controls and 41 patients with Graves' disease were typed for seven HLA DRw specificities. 28 patients with Graves' disease (68%) were positive for DRw3, in contrast to 14 controls (28%); whereas only 21 patients (50%) were HLA B8 positive, compared with 13 (26%) controls. Thus, positivity for DRw3 afforded a relative risk for Graves' disease of 5.5, whereas that for HLA B8 amounted to 3.0. Additionally, a family with multiple cases of Graves' disease in which the disease was previously shown to be inherited with the haplotype, was linked to DRw2, which suggests that the susceptibility to the disease was inherited in association with that antigen. Two HLA B/glyoxalase recombination events were observed in this family; in both instances HLA DRw followed HLA B. This study thus demonstrates that the disease susceptibility gene for Graves' disease is in strong linkage disequilibrium with DRw3; however, it may be associated with other DRw specificities and inherited within family units in association with them.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 105012      PMCID: PMC371924          DOI: 10.1172/JCI109263

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  Second genetic locus in the HLA region for human B-cell alloantigens.

Authors:  D L Mann; L Abelson; S Harris; D B Amos
Journal:  Nature       Date:  1976-01-15       Impact factor: 49.962

2.  Serological identification of Ia antigens: report of a British region Ia workshop.

Authors:  J Bodmer; P Pickbourne; W Bodmer; R Batchelor; P Dewar; H Dick; C Entwistle; H Festenstein; K Gelsthorpe; V Joysey; P Mackintosh; S Lawler; P Morris; G D Pegrum; R Harris; M Taylor
Journal:  Tissue Antigens       Date:  1976-11

Review 3.  The association between genes in the major histocompatibility complex and disease susceptibility,.

Authors:  T Sasazuki; H O McDevitt; F C Grumet
Journal:  Annu Rev Med       Date:  1977       Impact factor: 13.739

Review 4.  HL-A antigens and disease. Statistical and genetical considerations.

Authors:  A Svejgaard; C Jersild; L S Nielsen; W F Bodmer
Journal:  Tissue Antigens       Date:  1974

Review 5.  Histocompatibility-linked immune response genes.

Authors:  B Benacerraf; H O McDevitt
Journal:  Science       Date:  1972-01-21       Impact factor: 47.728

6.  HL-A antigens as markers for disease susceptibility and autoimmunity in Graves' disease.

Authors:  F C Grumet; R O Payne; J Konishi; J P Kriss
Journal:  J Clin Endocrinol Metab       Date:  1974-12       Impact factor: 5.958

7.  B-cell alloantigens determined by the H-2 linked Ir region are associated with mixed lymphocyte culture stimulation.

Authors:  E C Lozner; D H Sachs; G M Shearer; W D Terry
Journal:  Science       Date:  1974-02-22       Impact factor: 47.728

8.  Antibody response of C3H in equilibrium (CKB X CWB)F1 tetraparental mice to poly-L(Tyr,Glu)-poly-D,L-Ala-poly-L-Lys immunization.

Authors:  K B Bechtol; H O McDevitt
Journal:  J Exp Med       Date:  1976-07-01       Impact factor: 14.307

9.  Serologically defined and lymphocyte-defined components of the major histocompatibility complex in the mouse.

Authors:  F H Bach; M B Widmer; M L Bach; J Klein
Journal:  J Exp Med       Date:  1972-12-01       Impact factor: 14.307

10.  Antigen-specific T-cell factor in cell cooperation. Mapping within the I region of the H-2 complex and ability to cooperate across allogeneic barriers.

Authors:  M J Taussig; A J Munro; R Campbell; C S David; N A Staines
Journal:  J Exp Med       Date:  1975-09-01       Impact factor: 14.307

View more
  24 in total

1.  Exclusion of linkage to the HLA region in ninety multiplex sibships with autism.

Authors:  T Rogers; L Kalaydjieva; J Hallmayer; P B Petersen; P Nicholas; C Pingree; W M McMahon; D Spiker; L Lotspeich; H Kraemer; P McCague; S Dimiceli; N Nouri; T Peachy; J Yang; D Hinds; N Risch; R M Myers
Journal:  J Autism Dev Disord       Date:  1999-06

2.  Association study of autoimmune thyroid disease at 5q23-q33 in Japanese patients.

Authors:  Takashi Akamizu; Hitomi Hiratani; Satoshi Ikegami; Stephen S Rich; Donald W Bowden
Journal:  J Hum Genet       Date:  2003-04-09       Impact factor: 3.172

3.  Genetics of thyroid function and disease.

Authors:  Vijay Panicker
Journal:  Clin Biochem Rev       Date:  2011-11

4.  Organ specific and multisystemic autoimmune disease: part of a spectrum which may coexist in the same patient.

Authors:  T Gordon; D Isenberg
Journal:  Clin Rheumatol       Date:  1990-09       Impact factor: 2.980

5.  Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves disease.

Authors:  H Payami; S Joe; N R Farid; V Stenszky; S H Chan; P P Yeo; J S Cheah; G Thomson
Journal:  Am J Hum Genet       Date:  1989-10       Impact factor: 11.025

6.  The pathogenesis and treatment of Graves' ophthalmopathy.

Authors:  I R Jones
Journal:  Postgrad Med J       Date:  1987-09       Impact factor: 2.401

Review 7.  Genetics of autoimmune endocrine diseases.

Authors:  J F Bach; S Caillat-Zucman
Journal:  Springer Semin Immunopathol       Date:  1993

8.  Linkage analysis of "necessary" disease loci versus "susceptibility" loci.

Authors:  D A Greenberg
Journal:  Am J Hum Genet       Date:  1993-01       Impact factor: 11.025

9.  Linkage analysis versus association analysis: distinguishing between two models that explain disease-marker associations.

Authors:  S E Hodge
Journal:  Am J Hum Genet       Date:  1993-08       Impact factor: 11.025

10.  Myasthenia gravis: overlap with 'polyendocrine' autoimmunity.

Authors:  W A Scherbaum; F Schumm; B Maisch; C Müller; A Fateh-Moghadam; S H Flüchter; F J Seif; G F Bottazzo; P A Berg
Journal:  Klin Wochenschr       Date:  1983-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.